DE60118913D1 - Transgenes tiermodell für neurodegenerative erkrankungen - Google Patents

Transgenes tiermodell für neurodegenerative erkrankungen

Info

Publication number
DE60118913D1
DE60118913D1 DE60118913T DE60118913T DE60118913D1 DE 60118913 D1 DE60118913 D1 DE 60118913D1 DE 60118913 T DE60118913 T DE 60118913T DE 60118913 T DE60118913 T DE 60118913T DE 60118913 D1 DE60118913 D1 DE 60118913D1
Authority
DE
Germany
Prior art keywords
transgenic animal
animal model
neurodegenerative diseases
well
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118913T
Other languages
English (en)
Other versions
DE60118913T2 (de
Inventor
George-Hyslop H St
E Fraser
David Westaway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Toronto
Original Assignee
University of Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Toronto filed Critical University of Toronto
Application granted granted Critical
Publication of DE60118913D1 publication Critical patent/DE60118913D1/de
Publication of DE60118913T2 publication Critical patent/DE60118913T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Eye Examination Apparatus (AREA)
DE60118913T 2000-06-20 2001-06-19 Transgenes tiermodell für neurodegenerative erkrankungen Expired - Lifetime DE60118913T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21253400P 2000-06-20 2000-06-20
US212534P 2000-06-20
PCT/CA2001/000900 WO2001097607A2 (en) 2000-06-20 2001-06-19 Transgenic animal model of neurodegenerative disorders

Publications (2)

Publication Number Publication Date
DE60118913D1 true DE60118913D1 (de) 2006-05-24
DE60118913T2 DE60118913T2 (de) 2007-01-25

Family

ID=22791418

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60118913T Expired - Lifetime DE60118913T2 (de) 2000-06-20 2001-06-19 Transgenes tiermodell für neurodegenerative erkrankungen
DE60144164T Expired - Lifetime DE60144164D1 (de) 2000-06-20 2001-06-19 Transgenes Tiermodel für neurodegenerative Krankheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60144164T Expired - Lifetime DE60144164D1 (de) 2000-06-20 2001-06-19 Transgenes Tiermodel für neurodegenerative Krankheiten

Country Status (13)

Country Link
EP (3) EP1292187B1 (de)
JP (3) JP4938956B2 (de)
AT (2) ATE323408T1 (de)
AU (1) AU2001270377A1 (de)
CA (1) CA2407847C (de)
CY (1) CY1105122T1 (de)
DE (2) DE60118913T2 (de)
DK (1) DK1292187T3 (de)
ES (1) ES2262662T3 (de)
MX (1) MXPA02011516A (de)
PT (1) PT1292187E (de)
SI (1) SI1292187T1 (de)
WO (1) WO2001097607A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100994748B1 (ko) 2002-04-19 2010-11-17 더 가버닝 카운실 오브 더 유니버시티 오브 토론토 알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물
US7544855B2 (en) * 2004-04-23 2009-06-09 Buck Institute Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664
JP4590638B2 (ja) * 2006-03-20 2010-12-01 国立大学法人鳥取大学 家族性筋萎縮性側索硬化症（ｆａｌｓ）発症するトランスジェニックマウス
CL2007002908A1 (es) 2007-10-09 2008-05-30 Univ Concepcion Procedimiento electroquimico in vitro para evaluar capacidad neurotoxica de estructuras, principios activos y/o compuestos de interes en celulas vivas y que comprende medir y cuantificar los parametros electricos en membranas expuestas a dichos agreg
CA2703727A1 (en) * 2007-11-01 2009-05-07 F. Hoffmann-La Roche Ag Quadruple transgenic non-human animal
WO2010054324A2 (en) * 2008-11-10 2010-05-14 The Regents Of The University Of Colorado, A Body Corporate Methods for treating clinical conditions associated with lipoprotein lipase activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09507746A (ja) 1993-10-27 1997-08-12 アテナ ニューロサイエンシズ，インコーポレイティド Ｓｗｅｄｉｓｈ変異を有するＡＰＰ対立遺伝子を含有するトランスジェニック動物
JPH07132033A (ja) 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
ATE278023T1 (de) * 1994-01-27 2004-10-15 Univ Minnesota Nicht humane, transgenische säugetiere mit sich entwickelnder neurologischer krankheit
US5877399A (en) 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
CA2221986A1 (en) * 1995-06-07 1996-12-19 Athena Neurosciences, Inc. Method for identifying alzheimer's disease therapeutics using transgenic animal models
US5894078A (en) 1996-02-26 1999-04-13 Advanced Bioconcept, Inc. Transgenic mouse expressing C-100 app
WO1999009150A1 (en) * 1996-08-15 1999-02-25 Bayer Corporation Method of introducing modifications into a gene
US5898094A (en) 1996-10-21 1999-04-27 University Of South Florida Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease

Also Published As

Publication number Publication date
DE60118913T2 (de) 2007-01-25
WO2001097607A3 (en) 2002-12-12
WO2001097607A2 (en) 2001-12-27
JP4938956B2 (ja) 2012-05-23
PT1292187E (pt) 2006-07-31
ATE323408T1 (de) 2006-05-15
EP1292187B1 (de) 2006-04-19
EP1292187A2 (de) 2003-03-19
JP2009178162A (ja) 2009-08-13
JP5070236B2 (ja) 2012-11-07
EP1728423A2 (de) 2006-12-06
MXPA02011516A (es) 2005-07-01
DK1292187T3 (da) 2006-08-21
ES2262662T3 (es) 2006-12-01
EP1728423A3 (de) 2007-02-28
CY1105122T1 (el) 2010-03-03
SI1292187T1 (sl) 2006-10-31
JP2003535605A (ja) 2003-12-02
ATE499832T1 (de) 2011-03-15
EP2263453A1 (de) 2010-12-22
EP2263453B1 (de) 2018-06-13
DE60144164D1 (de) 2011-04-14
EP1728423B1 (de) 2011-03-02
JP2011172600A (ja) 2011-09-08
AU2001270377A1 (en) 2002-01-02
CA2407847A1 (en) 2001-12-27
CA2407847C (en) 2013-08-27

Similar Documents

Publication Publication Date Title
NO974964L (no) Genetiske sekvenser og proteiner som er relatert til Alzheimer's sykdom, og anvendelser av disse
DK0845939T3 (da) Lysosomale proteiner produceret i mælk fra ikke-humane transgene dyr
AU8448301A (en) Remedies for heart failure
BRPI0510123A (pt) modelos transgênicos de doença de alzheimer e seu uso no tratamento de uma variedade de doenças neurodegenerativas
DE60031512D1 (de) Diagnostika und therapeutika für maculare degeneration
ATE511348T1 (de) Transgenes modell für morbus alzheimer
ATE541923T1 (de) Transgener c. elegans als modellorganismus für untersuchungen zur alzheimer'schen krankheit
PL362437A1 (en) Diagnostics and therapeutics for glaucoma
AU6264996A (en) Method for identifying alzheimer's disease therapeutics usin g transgenic animal models
CY1105122T1 (el) Διαγενες μοντελο με νευροεκφυλιστικες διαταραχες
WO2001087055A3 (en) New screening tool for analyzing the behavior of laboratory animals
AU6168396A (en) Method for identifying alzheimer's disease therapeutics usin g transgenic animal models
CY1110788T1 (el) Διαγονιδιακα ζωα τα οποια παρουσιαζουν σημαντικες διαταραχες σχετικες με την νοσο alzheimer
NO20020010D0 (no) Transgene dyr som modeller for neurodegenerativ sykdom
DE60325519D1 (de) Doppel-transgenisches, nicht-humanes Säugertiermodell für die Alzheimer Krankheit
ATE473009T1 (de) Hemmung der neurodegeneration
ATE332078T1 (de) Tiermodel für neurodegenerative erkrankungen
WO2002101232A3 (en) Bace interacting proteins
DE9308704U1 (de) Hindernisstangenauflage für den Pferdespringsport
DE60239099D1 (de) Tier mit gen-hypoexpression
BR0107845A (pt) Diagnóstico do risco de uma pessoa desenvolver alcoolismo
WO2003002714A3 (en) Protein tyrosine phosphatase 2 gene disruptions, compositions and methods related thereto
WO2002079420A3 (en) Adam-like protease disruptions, compositions and methods related thereto
WO2004062627A3 (en) In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders
WO2002045497A3 (en) Transgenic mice containing dusp8 phosphatase gene disruptions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition